INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

MAIAMAIA Biotechnology, Inc.

CIK 0001878313

EDGAR filingsOpen in network
Disclosed transactions35
Buys / sells28 / 0
Max Insider Score54
Connections9with evidence

MAIA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
37
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$100K
73.0K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Guerrero RamiroDirector · Aug 24, 2026
  • ← Insider ofevidence
    Gryaznov SergeiChief Scientific Officer · Apr 14, 2026
  • ← Insider ofevidence
    Himmelreich Jeffrey CHead of Finance · Apr 14, 2026
  • ← Insider ofevidence
34
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY
$50K
37.6K sh
Sep 10, 2026
Sep 14, 2026
traded Sep 10, 2026
+4d
SEC FORM 4

Evidence

32
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$63K
46.6K sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC FORM 4

Evidence

38
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$109K
78.2K sh
Aug 27, 2026Sep 1, 2026
traded Aug 27, 2026
+5dSEC FORM 4

Evidence

31
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$12K
8,931 sh
Aug 26, 2026Sep 1, 2026
traded Aug 26, 2026
+6dSEC FORM 4

Evidence

25
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$2,386
1,794 sh
Aug 24, 2026Aug 26, 2026
traded Aug 24, 2026
+2dSEC FORM 4

Evidence

29
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$16K
11.9K sh
Aug 20, 2026Aug 24, 2026
traded Aug 20, 2026
+4dSEC FORM 4

Evidence

5
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Grant or award
A—
800.0K sh
May 29, 2026Jun 1, 2026
traded May 29, 2026
+3dSEC FORM 4

Evidence

9
GS
Gryaznov SergeiChief Scientific Officer
MAIAMAIA Biotechnology, Inc.
Grant or award
A—
400.0K sh
May 29, 2026Jun 1, 2026
traded May 29, 2026
+3dSEC FORM 4

Evidence

9
HC
Himmelreich Jeffrey CHead of Finance
MAIAMAIA Biotechnology, Inc.
Grant or award
A—
60.0K sh
May 29, 2026Jun 1, 2026
traded May 29, 2026
+3dSEC FORM 4

Evidence

9
GS
Gryaznov SergeiChief Scientific Officer
MAIAMAIA Biotechnology, Inc.
Grant or award
A—
400.0K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

9
HC
Himmelreich Jeffrey CHead of Finance
MAIAMAIA Biotechnology, Inc.
Grant or award
A—
30.0K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

5
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Grant or award
A—
800.0K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

44
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$9,959
2,700 sh
Sep 19, 2022Jan 12, 2026
traded Sep 19, 2022
+1211dSEC FORM 4

Evidence

23
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Gift
G—
20.0K sh
May 1, 2024Jan 12, 2026
traded May 1, 2024
+621dSEC FORM 4

Evidence

46
LY
Louie Ngar YeeDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$100K
81.7K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

35
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$70K
57.2K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

54
CM
Chaouki Steven MDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$56K
40.8K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

47
CM
Chaouki Steven MDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$50K
40.8K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

54
LY
Louie Ngar YeeDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$111K
81.7K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$78K
57.2K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$5,495
4,580 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$5,450
4,580 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$5,496
4,580 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

45
LC
Luput CristianDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$22K
20.0K sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC FORM 4

Evidence

42
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$57K
50.0K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC FORM 4

Evidence

41
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$23K
22.0K sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC FORM 4

Evidence

41
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$16K
15.0K sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC FORM 4

Evidence

35
LC
Luput CristianDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$20K
18.1K sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC FORM 4

Evidence

41
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$10K
10.5K sh
Nov 25, 2025Nov 28, 2025
traded Nov 25, 2025
+3dSEC FORM 4

Evidence

45
LC
Luput CristianDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$9,785
10.0K sh
Nov 25, 2025Nov 28, 2025
traded Nov 25, 2025
+3dSEC FORM 4

Evidence

35
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$15K
15.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC FORM 4

Evidence

35
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$9,900
10.0K sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence

35
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$9,891
10.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC FORM 4

Evidence

39
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$1,656
1,800 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC FORM 4

Evidence

Louie Ngar Yee
Director · Dec 23, 2025
  • ← Insider ofevidence
    Chaouki Steven MDirector · Dec 23, 2025
  • ← Insider ofevidence
    Luput CristianDirector · Nov 28, 2025
  • ← Insider ofevidence
    Smith StanDirector · Nov 26, 2025
  • ← Insider ofevidence
    Vitoc VladDirector, Chief Executive Officer, 10% Owner · Nov 25, 2025